Bill Kaelin
, the 2019 Nobel Prize Recipient in Medicine or Physiology and Leader of the Kaelin Lab for Cancer Biology · Mass General Brigham
Credentials: · ·
History
Internal Medicine
Research
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing
Science · 2001 · Last of 10 authors · 3,981 citations
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway
Review · Molecular Cell · 2008 · First of 2 authors · Corresponding · 2,678 citations
Nature Cell Biology · 2000 · Last of 9 authors · 1,304 citations
26 papers · 4 as a fellow
- WS
17 papers
14 papers
13 papers
12 papers · 5 as a fellow
10 papers · 1 as a fellow
9 papers
- DS
8 papers · 4 as a resident
Grants
- 2003–2031
National Cancer Institute · P50
PI · $27.6M · Beth Israel Deaconess Medical Center
- 2016–2030
National Cancer Institute · R35
Contact PI · $10.8M · Dana-Farber Cancer Inst
- 2013–2024
National Cancer Institute · P50
Project lead · $1.6M · Brigham and Women's Hospital
- 1996–2017
The von Hippel-Lindau Tumor Suppressor Protein:Roles in Cancer and Oxygen Sensing
National Cancer Institute · R01
Contact PI · $5.7M · Dana-Farber Cancer Inst